BALDISSARRO, ISABELLA
 Distribuzione geografica
Continente #
EU - Europa 1.136
AS - Asia 142
NA - Nord America 83
SA - Sud America 4
AF - Africa 3
Totale 1.368
Nazione #
IT - Italia 1.122
US - Stati Uniti d'America 76
SG - Singapore 44
VN - Vietnam 30
CN - Cina 28
BD - Bangladesh 26
FR - Francia 7
BR - Brasile 4
HK - Hong Kong 4
ID - Indonesia 4
CA - Canada 3
GB - Regno Unito 2
JP - Giappone 2
MX - Messico 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
DE - Germania 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
FI - Finlandia 1
HN - Honduras 1
IE - Irlanda 1
IN - India 1
MA - Marocco 1
PL - Polonia 1
TH - Thailandia 1
TR - Turchia 1
Totale 1.368
Città #
Genova 612
Genoa 314
Rapallo 93
Vado Ligure 86
San Jose 24
Singapore 19
Ashburn 10
Beijing 10
Ho Chi Minh City 10
Hanoi 9
Lauterbourg 6
Buffalo 4
Hong Kong 4
New York 4
Rome 3
Santa Clara 3
Atlanta 2
Biên Hòa 2
Bordighera 2
Bắc Ninh 2
Haiphong 2
São Paulo 2
Tokyo 2
Venice 2
Acalanes Ridge 1
Addis Ababa 1
Albino 1
Alwar 1
Ancona 1
Bang Lamung 1
Bayonne 1
Cairo 1
Canton 1
Cuauhtémoc 1
Da Nang 1
Dallas 1
Des Moines 1
Dubai 1
Dublin 1
Florence 1
Frankfurt am Main 1
Helsinki 1
Lille 1
London 1
Los Angeles 1
Memphis 1
Mexico City 1
Milan 1
Mississauga 1
Montreal 1
Naples 1
Orem 1
Parma 1
Phoenix 1
Pittsburgh 1
Pontiac 1
Rancho Cucamonga 1
Rio de Janeiro 1
Ronciglione 1
Safi 1
Salt Lake City 1
San Pedro Sula 1
Santo Domingo 1
Seattle 1
Tangerang 1
Tešanj 1
Toronto 1
Visalia 1
Wahiawa 1
Warsaw 1
Washington 1
Xangri-lá 1
Zibo 1
Totale 1.276
Nome #
Comparison of Two Different Techniques to Assess Adalimumab Trough Levels in Patients with Crohn's Disease. 218
High anti-TNF alfa drugs trough levels are not associated with the occurrence of adverse events in patients with inflammatory bowel disease 192
Cost per care of the first year of direct antiviral agents in the liguria region: A multicenter analysis 191
IL28B rs12979860 C/T polymorphism in elderly chronic hepatitis C patients treated with pegylated-interferon and ribavirin. 171
Adalimumab trough serum levels and anti-adalimumab antibodies in the long-term clinical outcome of patients with Crohn’s disease. 167
Reduction in TIMP-2 serum levels predicts remission of inflammatory bowel diseases 167
Low serum trough levels are associated with post-surgical recurrence in Crohn's disease patients undergoing prophylaxis with adalimumab. 160
Hepatic Elastometry and Glissonian Line in the Assessment of Liver Fibrosis 133
Totale 1.399
Categoria #
all - tutte 4.425
article - articoli 4.425
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.850


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202112 0 0 0 0 0 0 0 0 0 0 0 12
2021/202293 3 1 9 15 1 9 2 21 7 8 6 11
2022/2023110 10 14 1 21 13 15 0 11 12 1 8 4
2023/202464 4 5 1 9 5 18 2 3 2 2 4 9
2024/2025226 13 9 10 9 27 26 23 55 12 7 16 19
2025/2026356 54 6 25 19 53 23 45 5 14 34 21 57
Totale 1.399